Nagy JA, Masse EM, Herzberg KT, et al

Nagy JA, Masse EM, Herzberg KT, et al. months (range, 3 to 36 months). Of 16 assessable patients, best tumor responses observed were complete response (CR) in three patients (19%), partial response (PR) in two patients (12%), stable disease in nine patients (56%), and progressive disease in two patients (12%). GZD824 Overall response rate (CR … Continue reading Nagy JA, Masse EM, Herzberg KT, et al